Antibiotic resistance is racing toward a global crisis, with “superbugs” projected to cause over 10 million deaths annually by 2050. Now, scientists at UC San Diego have unveiled a powerful new CRISPR ...

Role reversal: Students from four Worcester schools evaluated advanced research projects, flipping the traditional science fair structure. Complex made clear: Researchers presented on CRISPR and ...

Researchers are transforming access to some of the world's oldest written records using digital technology and multilingual ...

Texas A&M University has broken ground on a $133.36 million Meat Science and Technology Center, designed to modernize research, teaching, and extension in meat science. The 85,600-square-foot facility ...

A child known publicly as Baby KJ was celebrated onstage at the twelfth Breakthrough Prize ceremony in Santa Monica last ...

Charles Gersbach and his colleagues are pursuing promising CRISPR technologies focused on controlling gene activity rather than permanently altering the genome.

The publication, titled “ Comparative characterization of Cas12f orthologs reveals mechanistic features underlying enhanced genome editing efficiency” highlights the potential of MG119-28 (formally ...

Scientists have taken an important step toward a gene therapy that could one day turn off the extra genetic material that causes Down syndrome (DS). Down syndrome is a genetic condition caused by an ...

Bread and biscuits made from Crispr-edited wheat showed substantially reduced acrylamide levels Scientists have developed gene-edited wheat that can be used to make bread that is less carcinogenic ...

CRISPR Cas9 genome editing has transformed the way scientists approach gene therapy, acting like precise DNA scissors that can target and repair hereditary diseases at the genetic level. This ...

CRISPR functions as a programmable genetic memory system derived from bacterial immune defenses against viral infections. Guide RNA allows for rapid multiplexed targeting compared to older ...

Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA regulatory pathway to commercialize treatments for rare diseases. Last February ...